Transurethral resection and degeneration of bladder tumour

Authors

  • Aihua Li Department of Urology, Yangpu District Central Hospital of Shanghai, Yangpu Hospital, Tongji University, Shanghai, China
  • Feng Zhang Department of Urology, Yangpu District Central Hospital of Shanghai, Yangpu Hospital, Tongji University, Shanghai, China
  • Wei Fang Department of Urology, Yangpu District Central Hospital of Shanghai, Yangpu Hospital, Tongji University, Shanghai, China
  • Weiwu Li Department of Urology, Yangpu District Central Hospital of Shanghai, Yangpu Hospital, Tongji University, Shanghai, China
  • Honghai Lu Department of Urology, Yangpu District Central Hospital of Shanghai, Yangpu Hospital, Tongji University, Shanghai, China
  • Sikuan Liu Department of Urology, Yangpu District Central Hospital of Shanghai, Yangpu Hospital, Tongji University, Shanghai, China
  • Xiaoqiang Qian Department of Urology, Yangpu District Central Hospital of Shanghai, Yangpu Hospital, Tongji University, Shanghai, China

DOI:

https://doi.org/10.5489/cuaj.363

Keywords:

Bladder tumor, Transurethral resection and degeneration, Outcome, Bladder preservation

Abstract

Introduction: We evaluate the efficacy and safety of transurethral resection and degeneration of bladder tumour (TURD-Bt).

Methods: In total, 56 patients with bladder tumour were treated by TURD-Bt. The results in these patients were compared with 32 patients treated by current transurethral resection of bladder tumour (TUR-Bt). Patients with or without disease progressive factors were respectively compared between the 2 groups. The factors included recurrent tumour, multiple tumours, tumour ≥3 cm in diameter, clinical stage T2, histological grade 3, adenocarcinoma, and ureteral obstruction or hydronephrosis.

Results: Follow-up time was 48.55 ± 23.74 months in TURD-Bt group and 56.28 ± 17.61 months in the TUR-Bt group (p > 0.05). In patients without progressive factors, no tumour recurrence was found and overall survival was 14 (100%) in the TURD-Bt group; 3 (37.50%) patients had recurrence and overall survival was 5 (62.5%) in the TUR-Bt group. In patients with progressive factors, 8 (19.05%) patients had tumour recurrence, overall survival was 32 (76.19%) and cancer death was 3 (7.14%) in TURD-Bt group; 18 (75.00%) patients had tumour recurrence (p < 0.05), overall survival was 12 (50.00%) (p < 0.01) and cancer death was 8 (33.33%) (p < 0.05) in TUR-Bt group. No significant complication was found in TURD-Bt group.

Conclusion: This study suggests that complete resection and degeneration of bladder tumour can be expected by TURD-Bt. The surgical procedure is safe and efficacious, and could be predictable and controllable before and during surgery. We would conclude that for bladder cancers without lymph node metastasis and distal metastasis, TURD-Bt could be performed to replace radical TUR-Bt and preserve the bladder.

Downloads

Download data is not yet available.

Downloads

Published

2013-12-05

How to Cite

Li, A., Zhang, F., Fang, W., Li, W., Lu, H., Liu, S., & Qian, X. (2013). Transurethral resection and degeneration of bladder tumour. Canadian Urological Association Journal, 7(11-12), e812–6. https://doi.org/10.5489/cuaj.363

Issue

Vol. 7 No. 11-12 (2013): CUAJ December

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.

Similar Articles

You may also start an advanced similarity search for this article.